tirzepatide canada availability MOUNJARO® (TIRZEPATIDE), THE FIRST AND ONLY SINGLE MOLECULE GIP AND GLP-1 RECEPTOR AGONIST FOR THE TREATMENT OF ADULTS WITH TYPE 2 DIABETES IS NOW AVAILABLE IN GLP-1 Access in Canada |
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18



























